Last updated: 2026-11-13 13:18:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
InspireMD, Inc. (NSPR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.66, with a market capitalization of $35.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.43 to $2.22. This page covers its latest market performance, valuation, price trends and company information.
$35.98M | |
$0.66 | |
$0.67 | |
$0.62 | |
$0.77 | |
15.26K | |
185.64K | |
-- | |
$2.22 | |
$0.43 | |
-- | |
-- |
InspireMD, Inc. (NSPR) is trading at $0.66 in pre-market trading as of 2026-11-13 13:13:00, down 14.34% ($0.11) from the previous close of $0.77
Pre-market trading shows how investors are pricing NSPR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
NSPR is up 3.21% in pre-market trading.
Over the past seven days, InspireMD, Inc. (NSPR) moved from $0.64 to $0.66, representing a gain of 3.76% ($0.02).
The stock traded between $0.60 and $0.82 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 386.58 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 13.2%
NSPR is currently trading at $0.66, placing it 13.2% of the way from its 52-week low of $0.43 to its 52-week high of $2.22. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 127 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to InspireMD, Inc. and NSPR stock.
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 35.29 percent increase over losses of $(0.17) per share from the
InspireMD (NSPR) beat earnings expectations with a loss of $0.11 per share versus consensus estimate of $0.15, representing a 26.67% earnings surprise. The company also surpassed revenue estimates at $2.24 million. However, shares have declined 55.1% year-to-date, significantly underperforming the S&P 500's 11.3% gain. The stock holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions.
Gainers Oragenics (AMEX:OGEN) stock increased by 30.2% to $0.46 during Thursday's after-market session. The market value of their outstanding shares is at $1.5 million. InspireMD (NASDAQ:NSPR) shares rose 13.88%
Eligible investors can buy real shares of InspireMD, Inc. (NSPR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NSPR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NSPR shares and USD.
NSPR Shares to USD
1.00 NSPR shares = 0.663 USD
Calculations are estimates based on the latest available price and are for reference only.
